Leucomax (Novartis)
Leucomax (Novartis) Brand names, Leucomax (Novartis) Analogs
Leucomax (Novartis) Brand Names Mixture
- No information avaliable
Leucomax (Novartis) Chemical_Formula
C639H1006N168O196S8
Leucomax (Novartis) RX_link
http://www.rxlist.com/cgi/generic/sargramostim.htm
Leucomax (Novartis) fda sheet
Leucomax (Novartis) msds (material safety sheet)
Leucomax (Novartis) Synthesis Reference
No information avaliable
Leucomax (Novartis) Molecular Weight
14434.5
Leucomax (Novartis) Melting Point
No information avaliable
Leucomax (Novartis) H2O Solubility
No information avaliable
Leucomax (Novartis) State
Liquid
Leucomax (Novartis) LogP
No information avaliable
Leucomax (Novartis) Dosage Forms
Solution (IV Infusion); Solution (Subcutaneous Injection)
Leucomax (Novartis) Indication
For the treatment of cancer and bone marrow transplant
Leucomax (Novartis) Pharmacology
Sargramostim is used in the treatment of bone marrow transplant recipients or those exposed to chemotherapy an recovering from acut myelogenous leukemia, Leukine or GM-CSF is a hematopoietic growth factor which stimulates the survival, clonal expansion (proliferation) and differentiation of hematopoietic progenitor cells. GM-CSF is also capable of activating mature granulocytes and macrophages. After a bone marrow transplant or chemotherapy, patients have a reduced capacity to produce red and white blood cells. Supplementing them with external sources of GM-CSF helps bring the level of neutrophils back to normal so that they can better fight infections.
Leucomax (Novartis) Absorption
No information avaliable
Leucomax (Novartis) side effects and Toxicity
No information avaliable
Leucomax (Novartis) Patient Information
No information avaliable
Leucomax (Novartis) Organisms Affected
No information avaliable
